Abstract:Abstract Psoriasis affects 2% of the UK population and is associated with significant costs for individuals and society, along with multiple comorbidities including psoriatic arthritis, cardiometabolic disease, and anxiety and depression. Most psoriasis is managed in the community; however, there is wide variation in assessment, diagnosis, treatment and secondary care referral pathways. We sought to evaluate the extent of psoriatic disease managed in the community, primarily under primary care. The aims of the study were to describe the clinical pattern of psoriasis in the community, to describe the burden of psoriatic disease comorbidities, and to explore why patients with severe psoriasis are not referred to secondary care. Participants were recruited over a 1-week period from a pop-up walk-in dermatology clinic run by dermatologists and rheumatologists in a city centre. Individuals who suspected they had psoriasis were invited to approach the study team. The presence or absence of psoriasis was then confirmed by a dermatologist. If psoriasis was confirmed, patients completed questionnaires including medical history, psoriasis treatment, Dermatology Life Quality Index (DLQI), Patient Health Questionnaire 9 (PHQ-9), Patient Needs Questionnaire 9, and Psoriasis Epidemiology Screening Tool (PEST). Clinical examination was documented using Psoriasis Area and Severity Index (PASI), body surface area and Physician’s Global Assessment. Statistical analyses were performed using RStudio (R Foundation, Vienna, Austria). Of > 300 patients screened, 140 were confirmed to have psoriasis. Overall, 46% (65) were male, the mean body mass index was 28.2 kg m−2, and 19% (26) currently smoked. Most (92%) had plaque psoriasis; 36% had concurrent nail involvement. The mean PASI was 4.6, with 34% (48) having a PASI > 5. The commonest comorbidities were cardiovascular disease (41%), depression (31%), anxiety (29%) and psoriatic arthritis (9%). Patients reported significant psychosocial impact, with a mean DLQI of 8.5, and 34% (48) scoring > 11 (severe or very severe impact). Similarly, the mean PHQ-9 was 8.1, with 35% (49) of patients scoring > 9 (moderate or severe depressive symptoms). In total, 73.6% were dissatisfied with their care, the commonest reason being lack of general practitioner appointments (31%). The team suggested a change of topical therapy to 84% (118) of patients and felt 29% (41) required referral to secondary care dermatology, including three urgent referrals. This study demonstrates a high prevalence of undertreated psoriasis in the community and the significant psychosocial impact of the participants’ skin disease. Going forward, improved communication between primary and secondary care services can enhance care for patients with psoriasis. Collaborative working between allied specialties, as demonstrated, can enhance research output and optimize patient outcomes. The research is supported by the NIHR infrastructure. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey

Psoriatic Arthritis Quality of Life Questionnaire: translation, cultural adaptation and validation into Brazilian Portuguese language

Development of a questionnaire to assess the patient perspective regarding challenges in psoriatic arthritis treatment-a mixed-methods study

Quality of Life in Psoriasis: A Cross-Sectional Study from North India

Magnitude of Psoriasis and Its Associated Factors, and Quality of Life of Psoriasis Patients among Patients Who Attend Dermatology Clinic at Tibebe Ghion Comprehensive Specialized and Addis Alem Primary Hospitals, North West Ethiopia, 2022: Institution-Based Cross-Sectional Study

Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities

Study of nutritional parameters and physical activity in psoriasis patients attended at a reference center in Northeastern Brazil / Estudo de parâmetros nutricionais e atividade física em pacientes com psoríase atendidos em um centro de referência no Nordeste do Brasil

O12 Community Psoriasis: Phenotype and Comorbidity Assessment (COPPACA): an observational study of the prevalence, phenotype and health burden of psoriasis in the community

Disease Burden and Quality of Life in Patients with Psoriasis: an Internet-Based Questionnaire

Brazilian version of the "Primary Sjögren's Syndrome - Quality of Life questionnaire (PSS-QoL)": translation, cross-cultural adaptation and validation

Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia

Jordanian Population's Perception and Understanding of Psoriasis: A Cross-Sectional Study

Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis

PSY28 DISEASE BURDEN AND QUALITY OF LIFE FOR PSORIASIS PATIENTS IN CHINA

Burden of Disease in Psoriatic Arthritis in Latin America: a Systematic Literature Review

Health Utility and Its Affacting Factors for Patients with Psoriasis in China

Prevalence of psoriasis and cutaneous mycoses: A descriptive study in Paraná, Brazil

The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis

Dietary patterns of patients with psoriasis at a public healthcare institution in Brazil